E. coli Exonuclease I (Exo I)
Product Introduction
Exo I (Exonuclease I) is a magnesium-dependent exonuclease derived from Escherichia coli that plays a fundamental role in molecular biology research. This enzyme consists of 475 amino acids with a molecular weight of approximately 54.5 kDa. Its three-dimensional structure presents a unique "C"-shaped conformation comprising three main domains: an N-terminal exonuclease active domain, an SH3 domain, and a C-terminal α-helical domain. The active center is located within a positively charged groove, enabling specific recognition and stable binding of single-stranded DNA (ssDNA) substrates, providing the structural basis for efficient catalysis.
Product Specifications
Parameter | Specification |
Source | Recombinant expression in E. coli |
Molecular Weight | ~55 kDa |
Concentration | 20,000 units/ml |
Activity | 3'→5' single-stranded DNA exonuclease activity |
Purity | ≥95% (SDS-PAGE) |
Endotoxin | <1 EU/μg |
Storage Buffer | 10 mM Tris-HCl, 100 mM NaCl, 0.5 mM EDTA, 5 mM β-ME, 100 μg/ml BSA, 50% Glycerol, pH 7.5 |
10× Reaction Buffer | 670 mM Glycine-KOH, 67 mM MgCl₂, 100 mM β-ME, pH 9.5 |
Storage Conditions | Long-term storage at -80°C; short-term storage at -20°C |
Product Specifications
Specifications | Catalog Number | Concentration | Volume |
1000 U | GR300101 | 20,000 U/mL | 50 μL |
5000 U | GR300102 | 20,000 U/mL | 250 μL |
100,000 U | GR300103 | 20,000 U/mL | 500 μL |
Application Scenarios
PCR Product Purification and Pre-Sequencing Treatment: Exo I is widely used to remove residual primers from PCR reactions. Leveraging its specific degradation of ssDNA, it efficiently eliminates unbound primers (containing 3'-hydroxyl termini), improving the quality of sequencing templates. This method is particularly critical in next-generation and third-generation sequencing technologies.
Molecular Diagnostics and Biosensors: Exo I is utilized in electrochemical biosensors for signal amplification. For example, when combined with nucleic acid aptamers and nano-silver probes, Exo I-mediated cyclic cleavage of ssDNA significantly enhances the detection sensitivity for target molecules (e.g., tumor markers). This technology offers the advantages of being label-free and having high stability.
References
Breyer WA, et al. (2000). Structure of Escherichia coli exonuclease I suggests how processivity is achieved. Nature Structural Biology. 7(12):1125-1128.